NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIA E-151-2017-0-JP-07 FATTY ACID DERIVATIVES AND THEIR USE JP National Stage 2019-572570 Issued
NIA E-151-2017-0-AU-03 FATTY ACID DERIVATIVES AND THEIR USE AU National Stage 2018297192 Issued
NIA E-151-2017-0-MX-09 FATTY ACID DERIVATIVES AND THEIR USE MX National Stage MX/a/2019/015730 Issued
NIA E-151-2017-0-PCT-02 FATTY ACID DERIVATIVES AND THEIR USE PCT PCT PCT/US2018/041086 Expired
NIA E-151-2017-0-CN-05 FATTY ACID DERIVATIVES AND THEIR USE CN National Stage 201880045287.6 Pending
NIA E-151-2017-0-HK-11 FATTY ACID DERIVATIVES AND THEIR USE HK National Stage 62020007841.3 Pending
NIA E-151-2017-0-KR-08 FATTY ACID DERIVATIVES AND THEIR USE KR National Stage 10-2020-7003568 Pending
NCI E-040-2012-0-MX-29 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen MX DIV MX/a/2018/008352 Issued
NCATS E-243-2017-0-US-02 USE OF LOW DOSE EMETINE FOR INHIBITION OF HUMAN CYTOMEGALOVIRUS (HCMV) US National Stage 16/068,208 11253511 Issued PDF
NCI E-140-2017-0-PCT-02 COMPOUNDS FOR TREATING CANCER PCT PCT PCT/US2018/040910 Expired
NCI E-065-2016-0-EP-03 COMBINATION OF HISTONE DEACETYLASE INHIBITOR AND IMMUNOTHERAPY EP National Stage 17702441.1 Abandoned
NCI E-520-2013-0-EP-08 HLA-A24 Agonist Epitopes Of MUC1-C Oncoprotein and Compositions and Methods of Use EP DIV 18181508.5 Abandoned
NIBIB E-128-2018-0-US-01 SYSTEMS AND METHODS FOR IMPROVED AXIAL RESOLUTION IN MICROSCOPY USING PHOTOSWITCHING AND STANDING WAVE ILLUMINATION TECHNIQUES US 62/693,750 Abandoned
NCI E-158-2018-0-US-01 ANTI-SLAMF7 CHIMERIC ANTIGEN RECEPTORS US 62/693,779 Abandoned
NIAID E-081-2013-4-US-13 PREFUSION RSV F PROTEINS AND THEIR USE US CON 16/025,858 11130785 Issued PDF
NIAID E-357-2001-1-US-29 West NIle Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine US DIV 16/025,624 10456461 Expired PDF
NCI E-116-2017-1-PCT-02 Human Antibodies Against CD33 PCT PCT PCT/US2018/040257 Expired
NCI E-213-2018-0-US-01 TRITERPENE AMINE DERIVATIVES US 62/692,071 Abandoned
NCI E-183-2017-0-IL-08 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains IL National Stage 271597 Issued
NCI E-183-2017-0-JP-09 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains JP National Stage 2019-572798 Issued
NCI E-183-2017-0-IT-19 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains IT EP 18759189.6 Issued
NCI E-183-2017-0-DE-20 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains DE EP 18759189.6 Issued
NCI E-183-2017-0-FR-17 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains FR EP 18759189.6 Issued
NCI E-183-2017-0-ES-21 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains ES EP 18759189.6 Issued
NCI E-183-2017-0-EP-07 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains EP National Stage 18759189.6 Issued
NCI E-183-2017-0-GB-18 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains GB EP 18759189.6 Issued
NCI E-065-2016-0-US-04 COMBINATION OF HISTONE DEACETYLASE INHIBITOR AND IMMUNOTHERAPY US National Stage 16/066,693 Abandoned
NCI E-183-2017-0-HK-01 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains HK EP 42023078902.6 Pending
NCI E-183-2017-0-PCT-02 ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS PCT PCT PCT/US2018/039917 Expired
NIAID E-148-2019-0-US-01 NON-NEUTRALIZING ANTIBODIES ELICITED BY RECOMBINANT LASSA-RABIES VACCINE ARE CRITICAL FOR PROTECTION AGAINST LASSA FEVER US 62/691,413 Abandoned
NCI E-183-2017-0-CA-05 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains CA National Stage 3068444 Pending
NCI E-183-2017-0-AU-03 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains AU National Stage 2018291128 Pending
NCI E-183-2017-0-KR-10 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains KR National Stage 2020-7002752 Pending
NCI E-183-2017-0-SG-12 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains SG National Stage 11201913175T Pending
NIAID E-145-2011-0-AU-13 Plasmodial Surface Anion Channel Inhibitors For The Treatment Or Prevention Of Malaria AU DIV 2018204659 Issued
NICHD E-157-2011-0-US-06 SMALL MOLECULE THERAPEUTIC COMPOUNDS TARGETING THIOESTERASE DEFICIENCY DISORDERS AND METHODS OF USING THE SAME US CON 16/020,392 Abandoned
NCATS E-178-2018-0-US-01 Cell-based High-throughput High-content Assays Using Glycolytic Enzymes For Drug Discovery US 62/690,027 Abandoned
NIAID E-261-2015-0-US-03 METHODS FOR INHIBITING HUMAN IMMUNODEFICIENCY VIRUS (HIV)
RELEASE FROM INFECTED CELLS 		US National Stage 16/065,854 Abandoned
NIAID E-099-2016-0-US-04 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US DIV 16/014,971 10206957 Abandoned PDF
NCI E-135-2018-0-US-01 METHOD AND APPARATUS FOR TESTING NEAR INFRARED-PHOTOIMMUNOTHERAPY TREATMENT US 62/688,031 Abandoned
NHLBI E-222-2022-3-US-01 Catheters and Manipulators with Deflectable Ends US 62/688,378 Expired
NICHD E-062-2015-0-CN-07 CODON-OPTIMIZED REDUCED-SIZE ATP7A CDNA AND USES FOR TREATMENT OF COPPER TRANSPORT DISORDERS CN National Stage 201680074686.6 Issued
NCI E-040-2012-0-JP-27 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen JP DIV 2018-117381 Issued
NCI E-085-2013-0-AU-11 Methods for Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood AU DIV 2018204458 Issued
NCATS E-104-2017-0-PCT-02 INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE AND HISTONE DEACETYLASE FOR TREATMENT OF CANCER PCT PCT PCT/US2018/038507 Expired
NCATS E-104-2017-0-US-03 INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE AND HISTONE DEACETYLASE FOR TREATMENT OF CANCER US National Stage 16/621,290 Abandoned
NHGRI E-100-2017-0-EP-04 CODON-OPTIMIZED HUMAN NPC1 GENES FOR THE TREATMENT OF NIEMANN-PICK TYPE C1 DEFICIENCY AND RELATED CONDITIONS EP National Stage 18740403.3 Abandoned
NCATS E-050-2012-0-JP-13 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases JP DIV 2018-116666 Pending
NHGRI E-100-2017-0-CA-03 CODON-OPTIMIZED HUMAN NPC1 GENES FOR THE TREATMENT OF NIEMANN-PICK TYPE C1 DEFICIENCY AND RELATED CONDITIONS CA National Stage 3068010 Pending
NHGRI E-100-2017-0-PCT-02 CODON-OPTIMIZED HUMAN NPC1 GENES FOR THE TREATMENT OF NIEMANN-PICK TYPE C1 DEFICIENCY AND RELATED CONDITIONS PCT PCT PCT/US2018/038584 Expired